We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-7.32%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$32.5B
AUM Growth
-$8.01B
Cap. Flow
-$4.75B
Cap. Flow %
-14.6%
Top 10 Hldgs %
6.24%
Holding
3,152
New
114
Increased
850
Reduced
1,973
Closed
197

Sector Composition

Rank Sector Weight
1 Healthcare 13.02%
2 Technology 11.49%
3 Consumer Discretionary 11.12%
4 Financials 10.82%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAM icon
776
Boston Beer
SAM
$1.92B
$9.44M 0.03%
44,802
-2,248
-5% -$497K
IONS icon
777
Ionis Pharmaceuticals
IONS
$9.01B
$9.4M 0.03%
232,583
-20,154
-8% -$1.04M
LFCR icon
778
Lifecore Biomedical
LFCR
$167M
$9.39M 0.03%
805,095
-436,962
-35% -$5.79M
EFR
779
Eaton Vance Senior Floating-Rate Fund
EFR
$315M
$9.32M 0.03%
706,894
+14,376
+2% +$196K
PAA icon
780
Plains All American Pipeline
PAA
$16.3B
$9.32M 0.03%
306,762
+92,729
+43% +$3.39M
HCC
781
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
$9.3M 0.03%
120,121
+8,683
+8% +$672K
VGK icon
782
Vanguard FTSE Europe ETF
VGK
$31.1B
$9.29M 0.03%
188,950
GOV
783
DELISTED
Government Properties Income Trust
GOV
$9.29M 0.03%
580,501
-87,697
-13% -$1.49M
CMCM
784
Cheetah Mobile
CMCM
$92.5M
$9.27M 0.03%
128,147
-20,006
-14% -$2.14M
DEO icon
785
Diageo
DEO
$49.2B
$9.26M 0.03%
85,905
+55,150
+179% +$6.13M
ACM icon
786
Aecom
ACM
$9.63B
$9.19M 0.03%
334,027
+108,696
+48% +$3.16M
AYI icon
787
Acuity Brands
AYI
$10.7B
$9.17M 0.03%
52,227
-3,539
-6% -$688K
PRI icon
788
Primerica
PRI
$10B
$9.16M 0.03%
203,274
-28,779
-12% -$1.26M
CPHD
789
DELISTED
Cepheid Inc
CPHD
$9.14M 0.03%
202,331
-12,730
-6% -$679K
KN icon
790
Knowles
KN
$3.38B
$9.13M 0.03%
495,669
-86,590
-15% -$1.48M
BIO icon
791
Bio-Rad Laboratories Class A
BIO
$9.31B
$9.11M 0.03%
67,857
-6,851
-9% -$986K
DHC
792
Diversified Healthcare Trust
DHC
$2.22B
$9.08M 0.03%
565,606
-843,030
-60% -$13.9M
ASRT
793
DELISTED
Assertio
ASRT
$9.07M 0.03%
8,022
+2,379
+42% +$4.06M
WSM icon
794
Williams-Sonoma
WSM
$29.2B
$9.06M 0.03%
237,442
-343,000
-59% -$14M
REG icon
795
Regency Centers
REG
$14.5B
$9.04M 0.03%
145,523
+6,239
+4% +$385K
ALKS icon
796
Alkermes
ALKS
$8.32B
$9.03M 0.03%
153,900
-45,162
-23% -$2.98M
BUI icon
797
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$726M
$9.03M 0.03%
555,345
-29,414
-5% -$524K
NKTR icon
798
Nektar Therapeutics
NKTR
$2.47B
$8.98M 0.03%
54,610
+4,395
+9% +$777K
TECH icon
799
Bio-Techne
TECH
$11.2B
$8.97M 0.03%
388,276
-4,484
-1% -$112K
IQI icon
800
Invesco Quality Municipal Securities
IQI
$528M
$8.92M 0.03%
733,795
+35,465
+5% +$423K

Similar funds

Guggenheim Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Guggenheim Capital held 3,152 positions worth $32.5B, down 20% from $40.5B the previous quarter. Its ten largest holdings account for 6.2% of the portfolio.

Guggenheim Capital withdrew a net $4.75B in Q3 2015, closing 197 positions and reducing 1,973 holdings. Its most notable exit was DIRECTV COM STK (DE), an estimated $84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Guggenheim Capital opened a new position in Kraft Heinz worth $72.7M.

  • Guggenheim Capital's largest Q3 2015 buy was Kraft Heinz: 1,030,574 shares worth $72.7M.
  • Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2015, an estimated $54.4M increase.
  • Guggenheim Capital's biggest Q3 2015 reduction was AGL Resources Inc, cutting an estimated $58M.
  • Guggenheim Capital fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $84M.
  • Guggenheim Capital's ten largest holdings make up 6.2% of its $32.5B portfolio in Q3 2015.
  • Guggenheim Capital opened 114 new positions and closed 197 in Q3 2015.
  • Guggenheim Capital's portfolio value fell 20% quarter-over-quarter to $32.5B.

Based on Guggenheim Capital's 13F filing for Q3 2015, filed 16 Nov 2015.